In vivo anti-tumor activity of PRP

In vivo anti-tumor activity of PRP

(A) Images of excised tumors at study termination of orthotropic pancreatic tumors. Mean tumor weight at termination day after daily I.V. injection of PBS, T/C 27.5/165 (mg/kg) or T/C 83.3/500 (mg/kg) (∗P < 0.05). (B) Images of excised tumors at study termination of orthotropic ovarian tumors. Mean tumor weight at termination day after daily I.V. injection of PBS, T/C 9.1/54 (mg/kg) or T/C 27.5/165 (mg/kg) (∗P < 0.05)

Format

PNG

Source

Propanc Biopharma, Inc.

Downloads